Chemical complementarity between immune receptor CDR3s and candidate cancer antigens correlating with reduced survival: evidence for outcome mitigation with corticosteroid treatments-Reference-Cited by-同舟云学术

Chemical complementarity between immune receptor CDR3s and candidate cancer antigens correlating with reduced survival: evidence for outcome mitigation with corticosteroid treatments

Published:2022-05-10 Issue: Volume: Page:1-9
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Patel Anishaa R.¹,Patel Dhruv N.¹,Tu Yaping N.¹,Yeagley Michelle¹,Chobrutskiy Andrea²,Chobrutskiy Boris I.³,Blanck George¹⁴^ORCID

Affiliation:

1. Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, FL, USA

2. Department of Pediatrics, Oregon Health and Science University Hospital, Portland, OR, USA

3. Department of Internal Medicine, Oregon Health and Science University Hospital, Portland, OR, USA

4. Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2022.2070546

Reference28 articles.

1. CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

2. Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates

3. The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation

4. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

5. High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical Complementarity of Tumor Resident, Adaptive Immune Receptor CDR3s and Previously Defined Hepatitis C Virus Epitopes Correlates with Improved Outcomes in Hepatocellular Carcinoma;Viral Immunology;2023-12-01

2. An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen;Oncoscience;2023-11-10

3. TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma;Cancer Biomarkers;2023-09-05

4. TRB CDR3 chemical complementarity with HBV epitopes correlates with increased hepatocellular carcinoma, disease‐free survival;Journal of Medical Virology;2023-08

5. Exploiting big data survival information to unify risk-stratification related, adaptive immune receptor parameters for multiple myeloma;Genes & Immunity;2023-07-13